Status:
UNKNOWN
Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
19-80 years
Brief Summary
Breast cancer (BC) is the most common cancer in women worldwide, and is the leading cause of death from cancer among women globally. Mammography is the standard method for early detection of BC in man...
Detailed Description
Breast cancer (BC) is the most common cancer in women worldwide, and is the leading cause of death from cancer among women globally. Mammography is the standard method for early detection of BC in man...
Eligibility Criteria
Inclusion
- All patients enrolled before initiation of any treatment.
Exclusion
- Any other malignant or benign tumors.
- Active inflammatory or autoimmune diseases.
- Renal or liver diseases.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT03474016
Start Date
July 1 2018
End Date
July 1 2020
Last Update
May 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.